"[Chronic intestinal failure] management requires complex technologies and multidisciplinary and multiprofessional activity and expertise dedicated to the care of both the underlying gastrointestinal condition and the home parenteral nutrition (HPN) support"

ESPEN GUIDELINES ON CHRONIC INTESTINAL FAILURE1

DISEASE MANAGEMENT

The gold-standard treatment for short bowel syndrome with intestinal failure (SBS-IF) patients is parenteral support (PS; PN/IV), as it provides the necessary nutritional and fluid requirements to maintain adequate health and/or growth.1,2

In addition to PS, other treatments may be used to manage the symptoms or the underlying cause of the disease. These treatments include.3

  • Anti-diarrhoeals (e.g. loperamide, codeine)
  • Anti-secretory agents (e.g. H2 receptor blockers, proton pump inhibitors)
  • Treatment with growth factors
  • Intestinal remodelling
  • Intestinal transplantation

For more details refer to the European Society of Clinical Nutrition and Metabolism (ESPEN) guidelines on chronic intestinal failure on adults.1

Date of preparation: May 2020 C-ANPROM/INT//7387